Related Experiment Videos
Southwestern Internal Medicine Conference: postmenopausal estrogen supplementation: a cardiologist's perspective
1University of Texas Southwestern Medical Center, Rogers Magnetic Resonance Center, Dallas 75235-9085.
Insights
Menopause increases coronary heart disease (CHD) risk due to lipid profile changes. Estrogen therapy may reduce CHD risk, but hormonal replacement therapy (HRT) benefits must be weighed against individual risks.
Area of Science:
- Cardiology
- Endocrinology
- Women's Health
Background:
- Postmenopausal women spend a significant portion of their lives with ceased ovarian function.
- Menopause presents health and disease implications, necessitating careful management of postmenopausal women.
- Understanding the risks and benefits of hormonal replacement therapy (HRT) is crucial.
Purpose of the Study:
- To discuss the relationship between menopause and coronary heart disease (CHD) risk.
- To evaluate the risks and benefits of HRT from a cardiologist's viewpoint.
- To assess estrogen's impact on CHD risk in postmenopausal women.
Main Methods:
- Review of existing data on menopause and CHD.
- Analysis of lipid profile changes during menopause.
- Evaluation of angiographic and prospective studies on estrogen use.
Main Results:
- Menopause is associated with lipid profile alterations that promote CHD development.
- Both natural and surgical menopause are linked to increased CHD risk.
- Estrogen use in postmenopausal women correlates with reduced CHD risk, primarily via lipid profile modification.
Conclusions:
- Menopause significantly impacts CHD risk, necessitating proactive cardiovascular assessment.
- Hormonal replacement therapy (HRT) may offer cardiovascular benefits, particularly through lipid management.
- The decision to use HRT should be individualized, balancing potential CHD risk reduction against overall patient risks and benefits.
Abstract:
Women live nearly one third of their lives after ovarian function has ceased. The implications of menopause for both health and disease as well as the risks and benefits of hormonal replacement therapy are important considerations in the management of postmenopausal women. The author discusses the relation between menopause and coronary heart disease (CHD) risk and evaluates the risks and benefits of hormonal replacement therapy from a cardiologist's perspective. During menopause, there are changes in the lipid profile that favor the development of CHD. In addition, there is convincing evidence that the risk of CHD increases with surgical menopause and that natural menopause also may signal a period of increasing risk. Data from angiographic and prospective studies suggest that a reduction in CHD risk is associated with estrogen use in postmenopausal women and that a large part of the beneficial effect of estrogen on CHD risk is through changes in the lipid profile. The benefit of hormonal replacement therapy for reduced risk of CHD, however, must be viewed in the setting of the overall risks and benefits of hormonal replacement therapy for each individual patient.